Zdrowie i gospodarka · 26/08/2015

FDA Extends Comment Period for Draft Guidance on Quality Metrics

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on quality metrics, following requests from interested parties to provide additional time to submit comments, in response to a public meeting and notice published in the Federal Register on July 28 and August 7, 2015.